Cetera Investment Advisers Astrazeneca PLC Transaction History

Cetera Investment Advisers

$44.2 Billion
Q3 2024

A detailed history of Cetera Investment Advisers transactions in Astrazeneca PLC stock. As of the latest transaction made, Cetera Investment Advisers holds 199,851 shares of AZN stock, worth $13.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

199,851

Previous 202,333 1.23%

Holding current value

$13.3 Million

Previous $15.8 Million 1.31%

% of portfolio

0.04%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$76.67 - $87.62 $190,294 - $217,472	-2,482 Reduced 1.23%	199,851 $15.6 Million
Q2 2024 Aug 22, 2024	SELL	$66.81 - $80.83 $345,006 - $417,406	-5,164 Reduced 2.49%	202,333 $15.8 Million
Q1 2024 May 24, 2024	BUY	$61.03 - $69.57 $9.85 Million - $11.2 Million	161,445 Added 350.57%	207,497 $14.1 Million
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $817,985 - $932,446	-13,403 Reduced 22.54%	46,052 $3.12 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $566,602 - $634,258	9,155 Added 18.2%	59,455 $4 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $300,709 - $332,472	-4,637 Reduced 8.44%	50,300 $3.41 Million
Q2 2023 Aug 09, 2023	SELL	$69.91 - $75.81 $368,076 - $399,139	-5,265 Reduced 8.75%	54,937 $3.93 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $304,319 - $345,040	4,819 Added 8.7%	60,202 $4.18 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $1.56 Million - $2.02 Million	-28,711 Reduced 34.14%	55,383 $3.75 Million
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $1.7 Million - $4.35 Million	32,054 Added 61.59%	84,094 $5,000
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $361,900 - $434,451	-6,107 Reduced 10.5%	52,040 $3.44 Million
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $224,384 - $270,292	-4,027 Reduced 6.48%	58,147 $3.86 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $180,210 - $212,936	-3,336 Reduced 5.09%	62,174 $3.62 Million
Q3 2021 Nov 16, 2021	BUY	$55.56 - $60.79 $447,091 - $489,177	8,047 Added 14.0%	65,510 $3.94 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $509,087 - $632,732	10,514 Added 22.39%	57,463 $3.44 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $79,841 - $92,166	-1,693 Reduced 3.48%	46,949 $2.33 Million
Q4 2020 Feb 17, 2021	BUY	$48.52 - $58.02 $2.05 Million - $2.46 Million	42,318 Added 669.17%	48,642 $2.43 Million
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $335,614 - $386,396	6,324 New	6,324 $347,000

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Astrazeneca PLC Transaction History